Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2009 | 1 |
2010 | 1 |
2013 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1.
Lancet. 2013.
PMID: 23219286
Free PMC article.
Clinical Trial.
Prevalence of reduced lung diffusing capacity and CT scan findings in smokers without airflow limitation: a population-based study.
Garcia-Rio F, Miravitlles M, Soriano JB, Cosío BG, Soler-Cataluña JJ, Casanova C, de Lucas P, Alfageme I, Rodríguez González-Moro JM, Sánchez Herrero MG, Ancochea J; EPISCAN II study.
Garcia-Rio F, et al.
BMJ Open Respir Res. 2023 Jan;10(1):e001468. doi: 10.1136/bmjresp-2022-001468.
BMJ Open Respir Res. 2023.
PMID: 36707127
Free PMC article.
Item in Clipboard
Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study.
Feliu J, Jorge Fernández M, Macarulla T, Massuti B, Albero A, González González JF, Quintero-Aldana G, Delgado-Mingorance JI, Fernández Montes A, García Piernavieja C, Valladares-Ayerbes M, López Muñoz AM, Mondéjar Solís R, Vicente P, Casado Gonzalez E, González Cebrián I, López-Vivanco G.
Feliu J, et al.
Cancer Chemother Pharmacol. 2021 Apr;87(4):543-553. doi: 10.1007/s00280-020-04214-w. Epub 2021 Jan 15.
Cancer Chemother Pharmacol. 2021.
PMID: 33452559
Clinical Trial.
Item in Clipboard
[Cardiovascular risk in subjects with high probability of metabolic syndrome and insulin resistance. DESIRE study].
Goday A, Gabriel R, Ascaso JF, Franch J, Ortega R, Martínez O, Lerones N; DESIRE study.
Goday A, et al.
Rev Clin Esp. 2008 Sep;208(8):377-85. doi: 10.1157/13126339.
Rev Clin Esp. 2008.
PMID: 18817695
Spanish.
Item in Clipboard
[Cardiovascular risk factor control in a population with longstanding diabetes attending endocrinology departments].
Comi-Diaz C, Miralles-García JM, Cabrerizo L, Pérez M, Masramon X, De Pablos-Velasco P; Grupo de Investigadores del Estudio Melodía, Sociedad Española de Endocrinología y Nutrición.
Comi-Diaz C, et al.
Endocrinol Nutr. 2010 Dec;57(10):472-8. doi: 10.1016/j.endonu.2010.09.003. Epub 2010 Nov 5.
Endocrinol Nutr. 2010.
PMID: 21115412
Spanish.
Item in Clipboard
[Evaluation of the quality of medical care in primary care patients with metabolic syndrome].
Modrego Navarro A, Ramírez Espinosa M, Fustero Fernández M, Tarraga López PJ, Bastida Calvo JC, Torras Tohà N; Grupo de Investigadores del Proyecto CAPSIME.
Modrego Navarro A, et al.
Rev Calid Asist. 2009 Aug;24(4):162-70. doi: 10.1016/S1134-282X(09)71800-7.
Rev Calid Asist. 2009.
PMID: 19647678
Spanish.
Item in Clipboard
Cite
Cite